We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $12.8B
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+25.52%
1 Year Est. Return
+48.82%
3 Year Est. Return
+110.09%
5 Year Est. Return
+134.03%
10 Year Est. Return
+612.52%
AUM
$9.53B
AUM Growth
+$1.89B
Cap. Flow
+$270M
Cap. Flow %
2.83%
Top 10 Hldgs %
11.36%
Holding
417
New
23
Increased
169
Reduced
161
Closed
41

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$39.8M
2
DAVA icon
Endava
DAVA
+$35.7M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$32.6M
4
HALO icon
Halozyme
HALO
+$30.3M
5
AZTA icon
Azenta
AZTA
+$29M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$67.2M
2
VRTU
Virtusa Corporation
VRTU
+$45.8M
3
SITE icon
SiteOne Landscape Supply
SITE
+$40.6M
4
PODD icon
Insulet
PODD
+$37.5M
5
FIVE icon
Five Below
FIVE
+$25.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.76%
2 Technology 15.98%
3 Industrials 14.75%
4 Consumer Discretionary 13.32%
5 Financials 12.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VICI icon
101
VICI Properties
VICI
$28.7B
$38.8M 0.41%
1,520,944
-17,229
-1% -$428K
MMYT icon
102
MakeMyTrip
MMYT
$5.65B
$38.8M 0.41%
1,313,320
-50,545
-4% -$1.15M
PE
103
DELISTED
PARSLEY ENERGY INC
PE
$38.5M 0.4%
2,713,340
+609,734
+29% +$7.26M
CHDN icon
104
Churchill Downs
CHDN
$6.16B
$38.4M 0.4%
394,650
-1,916
-0.5% -$174K
CACI icon
105
CACI
CACI
$15B
$37.4M 0.39%
150,046
+22,586
+18% +$5.2M
PRIM icon
106
Primoris Services
PRIM
$4.43B
$37.4M 0.39%
1,353,724
+142,874
+12% +$3.29M
NBIX icon
107
Neurocrine Biosciences
NBIX
$15.9B
$37.1M 0.39%
387,283
-1,820
-0.5% -$176K
CNS icon
108
Cohen & Steers
CNS
$4.39B
$36.7M 0.39%
494,490
+70,011
+16% +$4.62M
TCF
109
DELISTED
TCF Financial Corporation Common Stock
TCF
$36.7M 0.39%
991,870
+181,636
+22% +$5.77M
EXP icon
110
Eagle Materials
EXP
$6.49B
$36.7M 0.39%
362,004
+1,201
+0.3% +$112K
HMN icon
111
Horace Mann Educators
HMN
$2.09B
$36.4M 0.38%
864,713
-4,900
-0.6% -$189K
MOH icon
112
Molina Healthcare
MOH
$10.6B
$36.3M 0.38%
170,492
-45,139
-21% -$9.32M
ECL icon
113
Ecolab
ECL
$78.7B
$36.2M 0.38%
167,140
-1,338
-0.8% -$280K
PAYX icon
114
Paychex
PAYX
$42.6B
$36.1M 0.38%
387,798
-1,389
-0.4% -$123K
CATY icon
115
Cathay General Bancorp
CATY
$4.3B
$36.1M 0.38%
1,121,474
+115,743
+12% +$3.15M
ALGT icon
116
Allegiant Air
ALGT
$2.35B
$36.1M 0.38%
190,698
+21,034
+12% +$3.23M
AMGN icon
117
Amgen
AMGN
$225B
$36M 0.38%
156,476
-1,359
-0.9% -$313K
HALO icon
118
Halozyme
HALO
$11.5B
$36M 0.38%
+842,255
New +$30.3M
PGNY icon
119
Progyny
PGNY
$1.96B
$35.9M 0.38%
846,802
+181,412
+27% +$5.9M
MRK icon
120
Merck
MRK
$330B
$35.8M 0.38%
459,045
-3,158
-0.7% -$242K
HAE icon
121
Haemonetics
HAE
$4.08B
$35.2M 0.37%
296,351
+239
+0.1% +$25.7K
CME icon
122
CME Group
CME
$94.5B
$35.1M 0.37%
192,836
-1,423
-0.7% -$242K
CSCO icon
123
Cisco
CSCO
$490B
$34.6M 0.36%
773,521
-6,392
-0.8% -$263K
ICFI icon
124
ICF International
ICFI
$1.6B
$34.5M 0.36%
464,023
+63,635
+16% +$4.58M
CENTA icon
125
Central Garden & Pet Co Class A
CENTA
$2.44B
$34.3M 0.36%
1,179,853
-5,928
-0.5% -$174K
3 4
5
6 7

Similar funds

Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
ZIG
Zurich Insurance Group Zurich, Switzerland $12.7B AUM 53.57% 1-Year Est. Return
IMPI
Ilmarinen Mutual Pension Insurance Helsinki, Finland $12.7B AUM 16.27% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

GW&K Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, GW&K Investment Management held 417 positions worth $9.53B, up 25% from $7.64B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

GW&K Investment Management's Q4 2020 filing shows 23 new, 169 increased, 161 reduced and 41 closed positions. Its largest new stake was Medpace: 315,843 shares worth $44M. The largest sale was QuidelOrtho, an estimated $67.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • GW&K Investment Management's largest Q4 2020 buy was Medpace: 315,843 shares worth $44M.
  • GW&K Investment Management added most to Endava in Q4 2020, an estimated $35.7M increase.
  • GW&K Investment Management's biggest Q4 2020 reduction was QuidelOrtho, cutting an estimated $67.2M.
  • GW&K Investment Management fully exited Aimmune Therapeutics in Q4 2020, selling an estimated $10.2M.
  • GW&K Investment Management's ten largest holdings make up 11% of its $9.53B portfolio in Q4 2020.
  • GW&K Investment Management opened 23 new positions and closed 41 in Q4 2020.
  • GW&K Investment Management's portfolio value rose 25% quarter-over-quarter to $9.53B.

Based on GW&K Investment Management's 13F filing for Q4 2020, filed 5 Feb 2021.